Merck’s Keytruda will soon lose exclusivity, just as weight-loss giants Eli Lilly and Novo Nordisk press in with their ...

Amid efforts on several fronts to improve the affordability of its GLP-1 medications for diabetes and obesity, Novo Nordisk ...

Weight-loss drug pioneer Novo Nordisk will invest €432 million in upgrading its Athlone plant to produce the tablet form of ...

Pharmaceutical company Novo Nordisk has announced a €430m expansion of its manufacturing operation in Athlone which will see it produce the tablet form of its weight loss drug Wegovy.

GLP‑1 drugs are reshaping appetite, cravings and taste perception. Discover new research and what it means for food and drink ...

Goodpath supports both oral and injectable Wegovy options, enabling clinicians to tailor treatment to individual patient needs ...

Discover Vivani Medical's GLP-1 implant offering steady, reversible drug delivery to enhance adherence and reduce unnecessary ...

Novo Nordisk investors get a second bite at the Ozempic apple.

Scroll through social media for five minutes and you will see it. Dramatic before-and-after photos. Red carpet reveals.

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Morgan Stanley names Nvidia a top pick Morgan Stanley said it sees an attractive entry point. "For the last two quarters ...

Danish drugmaker Novo Nordisk A/S was at the forefront of the weight-loss injection boom as people discovered that its ...